Transurethral resection of the prostate: Difference between revisions
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Interventions infobox | | {{Interventions infobox | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
| Line 12: | Line 11: | ||
{{SCC}} | {{SCC}} | ||
==Overview== | ==Overview== | ||
| Line 23: | Line 22: | ||
{{Urogenital surgical procedures}} | {{Urogenital surgical procedures}} | ||
[[Category:Urology]] | [[Category:Urology]] | ||
Latest revision as of 17:03, 20 August 2012
Template:Interventions infobox Template:Search infobox Steven C. Campbell, M.D., Ph.D.
Overview
Transurethral resection of the prostate (also known as TURP, plural TURPs and as a transurethral prostatic resection TUPR) is a urological operation. It is used to treat benign prostatic hyperplasia (BPH). As the name indicates, it is performed by visualising the prostate through the urethra and removing tissue by electrocautery or sharp dissection. This is considered the most effective treatment for BPH. This procedure is done with spinal or general anesthetic. A large triple lumen catheter is inserted through the urethra to irrigate and drain the bladder after the surgical procedure is complete. Outcome is considered excellent for 80-90% of BPH patients. As with all invasive procedures, the patient should first discuss medications they are taking with their doctor, most especially blood thinners or anticoagulants, such as warfarin (Coumadin), or aspirin. These may need to be discontinued prior to surgery. Postop complications include bleeding (most common), clotting and hyponatremia (due to bladder irrigation).
See also
Template:Urogenital surgical procedures de:Transurethrale_Resektion